Genome-wide CRISPR-screening identifies p53 as regulator of cancer cell sensitivity to the histone evicting anthracycline aclarubicin
- DOI
- 10.1038/s41419-026-09138-6
- Published
- 2026-08-05
- Container
- Cell Death & Disease
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41419-026-09138-6,
title = {Genome-wide CRISPR-screening identifies p53 as regulator of cancer cell sensitivity to the histone evicting anthracycline aclarubicin},
author = {Sabina Y. van der Zanden and Koen Schipper and Merle A. van Gelder and Amina Teunisse and Jay Sarthy and Aart G. Jochemsen and Ruud H. M. Wijdeven and Jacques Neefjes},
year = {2026},
journal = {Cell Death \& Disease},
doi = {10.1038/s41419-026-09138-6},
url = {https://doi.org/10.1038/s41419-026-09138-6}
}RIS
TY - JOUR TI - Genome-wide CRISPR-screening identifies p53 as regulator of cancer cell sensitivity to the histone evicting anthracycline aclarubicin AU - Sabina Y. van der Zanden AU - Koen Schipper AU - Merle A. van Gelder AU - Amina Teunisse AU - Jay Sarthy AU - Aart G. Jochemsen AU - Ruud H. M. Wijdeven AU - Jacques Neefjes PY - 2026 JO - Cell Death & Disease DO - 10.1038/s41419-026-09138-6 UR - https://doi.org/10.1038/s41419-026-09138-6 ER -
APA
Zanden, S. Y. V. D., Schipper, K., Gelder, M. A. V., Teunisse, A., Sarthy, J., Jochemsen, A. G., Wijdeven, R. H. M., & Neefjes, J. (2026). Genome-wide CRISPR-screening identifies p53 as regulator of cancer cell sensitivity to the histone evicting anthracycline aclarubicin. Cell Death & Disease. https://doi.org/10.1038/s41419-026-09138-6
Source records
- crossref · retrieved 2026-11-10T15:10:00.633Z